Baruch D. Kuppermann
- Ophthalmology top 0.05%
- Retinal Diseases and Treatments 130
- Retinal and Optic Conditions 48
- Ocular Diseases and Behçet’s Syndrome 36
- Glaucoma and retinal disorders 34
-
- Retinal and Macular Surgery 43
- Retinal Imaging and Analysis 37
- Virology top 2%
- Pharmaceutical Science top 1%
- Epidemiology top 2%
- Cytomegalovirus and herpesvirus research 30
-
- Retinal Development and Disorders 31
Baruch D. Kuppermann
231 papers receiving 7.3k citations
Hit Papers
Peers
Comparison fields: 5 of 131
- Ophthalmology 5.2k
- Radiology, Nuclear Medicine and Imaging 2.9k
- Virology 324
- Pharmaceutical Science 268
- Epidemiology 1.5k
Countries citing papers authored by Baruch D. Kuppermann
This map shows the geographic impact of Baruch D. Kuppermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Baruch D. Kuppermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Baruch D. Kuppermann more than expected).
Fields of papers citing papers by Baruch D. Kuppermann
This network shows the impact of papers produced by Baruch D. Kuppermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Baruch D. Kuppermann. The network helps show where Baruch D. Kuppermann may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Baruch D. Kuppermann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 18 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 2 | |
| 4 | 2021 | 61 | |
| 5 | Intravitreal Injection of Allogeneic Human Retinal Progenitor Cells (hRPC) for Treatment of Retinitis Pigmentosa: A Prospective Randomized Controlled Phase 2b Trial | 2021 | 3 |
| 6 | Safety and Efficacy of Risuteganib in Intermediate Non-exudative Age-Related Macular Degeneration | 2020 | 3 |
| 7 | 2019 | 19 | |
| 8 | 2019 | 2 | |
| 9 | Reactive Oxygen Species Levels in Human Retinal Pigment Epithelium Cells In vitro to anti-VEGF Agents: Ranibizumab, Bevacizumab, Aflibercept and Ziv-aflibercept | 2015 | 2 |
| 10 | Effects of Ranibizumab, Bevacizumab, Aflibercept and Ziv-aflibercept on Cultured Human Retinal Müller Cells | 2014 | 1 |
| 11 | Integrin Peptide Therapy: A New Class of Treatment for Vascular Eye Diseases - The First Human Experience in DME | 2012 | 2 |
| 12 | The Phase III MIVI-TRUST Clinical Trial Data: Subgroup Responder Analysis of a Single Intravitreal Injection of Ocriplasmin in patients with Vitreomacular Traction | 2012 | 3 |
| 13 | 2011 | 3 | |
| 14 | Evaluation of in vitro Effects of Triamcinolone Acetonide and Dexamethasone on Human Lens Epithelial Cells | 2008 | 1 |
| 15 | Efficacy and Safety of a Novel Intravitreous Dexamethasone Drug–Delivery System After Applicator or Incisional Placement in Patients With Macular Edema | 2006 | 4 |
| 16 | Intravitreal Bioerudivel Sustained–Release Triamcinolone Microspheres System (RETAAC): Safety and Pharmacokinetic in the Rabbit Eye and a Preliminary Report of its Potential Usefulness for the Treatment Diabetic Macular Edema | 2006 | 3 |
| 17 | An Intravitreous Dexamethasone Bioerodible Drug Delivery System for the Treatment of Persistent Diabetic Macular Edema | 2003 | 8 |
| 18 | Treatment of Persistent Macular Edema (PME) Associated With Uveitis or Irvine-Gass Syndrome (IGS) With an Intravitreal Bioerodible Sustained Dexmethasone Release Implant; a Prospective Controlled Multi-Center Clinical Trial | 2003 | 3 |
| 19 | Treatment of Persistent Macular Edema Associated With Central and Branch Retinal Vein Occlusion With Extended Delivery of Intravitreal Dexamethasone | 2003 | 3 |
| 20 | 1998 | 72 |
About Baruch D. Kuppermann
Baruch D. Kuppermann is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Immunology, having authored 242 papers that have together received 7.6k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (130 papers), Retinal and Optic Conditions (48 papers), Retinal and Macular Surgery (43 papers), Retinal Imaging and Analysis (37 papers), Ocular Diseases and Behçet’s Syndrome (36 papers), Glaucoma and retinal disorders (34 papers), Retinal Development and Disorders (31 papers) and Cytomegalovirus and herpesvirus research (30 papers). The work is most often cited by research in Ophthalmology (5.2k citations), Radiology, Nuclear Medicine and Imaging (2.9k citations) and Virology (324 citations). Baruch D. Kuppermann has collaborated with scholars based in United States, India and Israel. Frequent co-authors include M. Cristina Kenney, Scott M. Whitcup, Ashish Sharma, Daniel Martín, Francesco Bandello, Raja Narayanan, Michael R. Robinson, Nilesh Kumar, Devin Welty and Marilyn Chwa. Their work appears in journals such as Nature, New England Journal of Medicine and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.